Author
Listed:
- Divija Deshpande
(University Hospital of Heidelberg
Heidelberg University, INF 366
Charité -Universitätsmedizin Berlin)
- Nitin Agarwal
(Heidelberg University, INF 366)
- Thomas Fleming
(University Hospital of Heidelberg
German Center for Diabetes Research (DZD))
- Claire Gaveriaux-Ruff
(Institut de Génétique et de Biologie Moléculaire et Cellulaire, Department of Translational Medicine and Neurogenetics
Université de Strasbourg
Centre National de la Recherche Scientifique
Institut National de la Santé et de la Recherche Médicale)
- Christoph S. N. Klose
(Charité -Universitätsmedizin Berlin)
- Anke Tappe-Theodor
(Heidelberg University, INF 366)
- Rohini Kuner
(Heidelberg University, INF 366)
- Peter Nawroth
(University Hospital of Heidelberg
German Center for Diabetes Research (DZD)
Joint Heidelberg-IDC Translational Diabetes Program, Helmholtz Zentrum)
Abstract
Painful neuropathy is a frequent complication in diabetes. Proopiomelanocortin (POMC) is an endogenous opioid precursor peptide, which plays a protective role against pain. Here, we report dysfunctional POMC-mediated antinociception in sensory neurons in diabetes. In streptozotocin-induced diabetic mice the Pomc promoter is repressed due to increased binding of NF-kB p50 subunit, leading to a loss in basal POMC level in peripheral nerves. Decreased POMC levels are also observed in peripheral nervous system tissue from diabetic patients. The antinociceptive pathway mediated by POMC is further impaired due to lysosomal degradation of μ-opioid receptor (MOR). Importantly, the neuropathic phenotype of the diabetic mice is rescued upon viral overexpression of POMC and MOR in the sensory ganglia. This study identifies an antinociceptive mechanism in the sensory ganglia that paves a way for a potential therapy for diabetic neuropathic pain.
Suggested Citation
Divija Deshpande & Nitin Agarwal & Thomas Fleming & Claire Gaveriaux-Ruff & Christoph S. N. Klose & Anke Tappe-Theodor & Rohini Kuner & Peter Nawroth, 2021.
"Loss of POMC-mediated antinociception contributes to painful diabetic neuropathy,"
Nature Communications, Nature, vol. 12(1), pages 1-18, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-020-20677-0
DOI: 10.1038/s41467-020-20677-0
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-020-20677-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.